Source: BioFire Diagnostics Official Website and Product Labeling
source confidence: Medium status: Useful updated 2026-06-18
Summary
BioFire's official websites and product labeling (biofiredx.com and the BioFire Defense product pages, plus bioMérieux's BioFire panel information sheets) describing the FilmArray syndromic-testing platform and the panel menu, including the FDA-cleared Global Fever Panel.
Useful Claims
- BioFire Diagnostics, LLC is part of bioMérieux; this capture does not show a Salt Lake City street address.
- The FilmArray platform runs multiplex-PCR syndromic infectious-disease testing with results in about one hour.
- This capture does not establish the Global Fever Panel specifications reported elsewhere (six targets, ~50 minutes, DEN200043) or an RUO variant.
- The published panel menu spans respiratory, gastrointestinal, blood culture identification, meningitis/encephalitis, and pneumonia testing.
Verbatim
"bioMérieux is now the corporate brand and BioFire has transitioned to a product franchise brand." — Home page, branding notice
"The BIOFIRE System is the new standard for syndromic infectious disease diagnostics . Simple, fast, and comprehensive, the BIOFIRE System delivers accurate results in about one hour." — Home page, FilmArray system
"The FDA-cleared BIOFIRE System panels test for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes." — Home page, panel menu
"BIOFIRE has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BIOFIRE System." — Home page, company positioning
Reliability Notes
This capture is the biofiredx.com marketing home page. Global Fever Panel specifications require separate product-labeling source records.